Numerai’s Cellebrite CLBT Stock Holding History

Numerai’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-25,857	Closed	-$435K	–	411
2024 Q3	$435K	Sell	25,857 -231,160	-90%	-$3.43M	0.12%	238
2024 Q2	$3.07M	Buy	+257,017	New	+$2.87M	1.12%	14

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Crosslink Capital Menlo Park, California $1.02B AUM 9.21% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return

Numerai's CLBT Position: Q4 2024 in Review

Numerai sold out of Cellebrite (CLBT) in Q4 2024, closing a stake of 25,857 shares — an estimated $435K sold.

Numerai first reported a position in CLBT in Q2 2024 and held it in 2 quarters. The position peaked at $3.07M in Q2 2024. 191 funds tracked by Wall St. Rank hold CLBT as of Q4 2024.

Numerai reported no remaining Cellebrite position as of Q4 2024 after selling out during the quarter.
Numerai sold 25,857 Cellebrite shares in Q4 2024, an estimated $435K.
Numerai first reported a position in Cellebrite in Q2 2024 and held it in 2 quarters.
Numerai's Cellebrite position peaked at $3.07M in Q2 2024.
191 funds tracked by Wall St. Rank held Cellebrite as of Q4 2024.

Based on Numerai's 13F filing for Q4 2024, filed 14 Feb 2025.